Lansforsakringar Fondforvaltning AB (publ)
Position in DHR — Danaher Corp /De/
CIK 2059323
Stockholm, V7
Position in DHR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$37,407,986
-$1,688,102 QoQ
Shares Held
196,388
-4.8% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#245
of 2,098 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Lansforsakringar Fondforvaltning AB (publ) holds $191,892,065 across 12 Diagnostics & Research names. DHR ranks #2 (19.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
131,916 | $66,137,405 | |
| 2 | DHR |
Danaher Corp /De/
This page
|
196,388 | $37,407,986 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
24,161 | $12,719,316 | |
| 4 | A |
Agilent Technologies, Inc.
|
88,456 | $11,749,610 | |
| 5 | WAT |
Waters Corp /De/
|
30,952 | $11,608,238 | |
| 6 | NTRA |
Natera, Inc.
|
40,580 | $11,015,441 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
51,226 | $9,897,887 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
6,414 | $8,193,949 |
All Filings in DHR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $37,407,986 | 196,388 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $39,096,088 | 206,203 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $47,371,560 | 206,935 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $39,908,944 | 201,296 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $39,123,192 | 198,052 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $43,214,615 | 210,803 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $50,112,142 | 218,306 | Shares | Sole | 2025-04-14 | |
| No filing history on record for this holder in this stock. | ||||||